| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
| Total Income - EUR | 450 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
| Total Expenses - EUR | 3.461 | 543 | 525 | 516 | 253 | - | - | - | - | 0 |
| Gross Profit/Loss - EUR | -3.011 | -543 | -525 | -516 | -253 | - | - | - | - | 0 |
| Net Profit/Loss - EUR | -3.025 | -543 | -525 | -516 | -253 | - | - | - | - | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
Check the financial reports for the company - One & One Vivamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
| Current Assets | 637 | 633 | 622 | 611 | 928 | - | - | - | - | 886 |
| Inventories | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
| Receivables | 636 | 630 | 619 | 608 | 926 | - | - | - | - | 883 |
| Cash | 1 | 3 | 3 | 3 | 3 | - | - | - | - | 3 |
| Shareholders Funds | -32.614 | -32.824 | -32.794 | -32.708 | -32.328 | - | - | - | - | -30.840 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | - | - | - | - | 80 |
| Debts | 33.251 | 33.457 | 33.416 | 33.319 | 33.256 | - | - | - | - | 31.726 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2120 - 2120" | |||||||||
| CAEN Financial Year |
2120
|
|||||||||
Comments - One & One Vivamed Srl